BioTuesdays

Tag - fatty liver disease

Galectin targets silent epidemic in liver fibrosis

By Len Zehr Fatty liver disease, or the accumulation of fat in liver cells, is a “silent epidemic,” says Dr. Peter Traber, president, CEO and chief medical officer of Galectin Therapeutics (NASDAQ:GALT). In an interview...